1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Vifor Pharma AG
  6. Financials
    VIFN   CH0364749348

VIFOR PHARMA AG

(VIFN)
  Report
Delayed Quote. Delayed Swiss Exchange - 05/27 11:31:37 am
171.3 CHF   +1.06%
05/12Update on the timeline for Vifor Pharma tender offer
BU
05/11Australia shares slide as U.S. inflation data fuels slowdown woes
RE
04/29VIFOR PHARMA AG : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 11 4559 02010 52311 116--
Enterprise Value (EV)1 11 5548 83010 52310 47710 0959 784
P/E ratio 72,1x25,1x-39,2x32,0x27,4x
Yield 1,13%1,44%-1,24%1,26%1,17%
Capitalization / Revenue 6,10x5,29x6,00x5,53x4,89x4,61x
EV / Revenue 6,15x5,18x6,00x5,21x4,44x4,06x
EV / EBITDA 21,4x15,3x17,5x14,8x12,4x11,5x
Price to Book 3,45x2,53x-2,71x2,52x2,29x
Nbr of stocks (in thousands) 64 84464 89464 85564 891--
Reference price (CHF) 177139162171171171
Announcement Date 03/12/202003/03/202102/17/2022---
1 CHF in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1 8771 7061 7542 0102 2722 413
EBITDA1 540576602706814850
Operating profit (EBIT)1 325291-490588653
Operating Margin 17,3%17,1%-24,4%25,9%27,0%
Pre-Tax Profit (EBT)1 310265-477567637
Net income1 159360-315376445
Net margin 8,48%21,1%-15,7%16,5%18,4%
EPS2 2,455,53-4,375,356,25
Dividend per Share2 2,002,00-2,122,162,00
Announcement Date 03/12/202003/03/202102/17/2022---
1 CHF in Million
2 CHF
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2018 S2 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1
Net sales1 837913964923783859
EBITDA1 200255285305271281
Operating profit (EBIT)1 112149176135156177
Operating Margin 13,4%16,3%18,3%14,6%20,0%20,6%
Pre-Tax Profit (EBT)1 112-170-147213
Net income1 34,465,293,967,9292124
Net margin 4,11%7,14%9,74%7,36%37,2%14,5%
EPS2 0,521,001,451,723,811,91
Dividend per Share ------
Announcement Date 03/14/201908/08/201903/12/202008/06/202003/03/202108/05/2021
1 CHF in Million
2 CHF
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 99,3-----
Net Cash position1 -191-6391 0211 331
Leverage (Debt / EBITDA) 0,18x-0,33x--0,91x-1,26x-1,57x
Free Cash Flow1 477355-464617-
ROE (Net Profit / Equities) 5,00%9,42%-9,82%10,3%11,5%
Shareholders' equity1 3 1853 816-3 2063 6563 879
ROA (Net Profit / Asset) 3,37%6,40%-6,55%7,33%7,13%
Assets1 4 7155 622-4 8075 1306 239
Book Value Per Share2 51,255,0-63,268,074,7
Cash Flow per Share2 8,076,52-8,519,4810,9
Capex1 48,068,5-11784,384,8
Capex / Sales 2,56%4,02%-5,81%3,71%3,52%
Announcement Date 03/12/202003/03/202102/17/2022---
1 CHF in Million
2 CHF
Previous periodNext period
Estimates
Key data
Capitalization (CHF) 11 115 886 199
Capitalization (USD) 11 623 726 824
Net sales (CHF) 1 754 200 000
Net sales (USD) 1 834 342 420
Number of employees 2 200
Sales / Employee (CHF) 797 364
Sales / Employee (USD) 833 792
Free-Float 72,2%
Free-Float capitalization (CHF) 8 029 320 635
Free-Float capitalization (USD) 8 396 148 356
Avg. Exchange 20 sessions (CHF) 10 335 574
Avg. Exchange 20 sessions (USD) 10 807 765
Average Daily Capital Traded 0,09%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA